Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pier Giovanni Baraldi

Showing results (101-110 of 159) with videos related to

Pageof 16
Sort By:
Bioorganic & Medicinal Chemistry Letters|June 5, 2004
[3H]-MRE 2029-F20, a selective antagonist radioligand for the human A2B adenosine receptorsPier Giovanni Baraldi, Mojgan Aghazadeh Tabrizi, Delia Preti, et al.
Journal of Medicinal Chemistry|August 9, 2002
Synthesis, biological properties, and molecular modeling investigation of the first potent, selective, and water-soluble human A(3) adenosine receptor antagonistAnna Maconi, Giorgia Pastorin, Tatiana Da Ros, et al.
Journal of Medicinal Chemistry|August 9, 2002
Design, synthesis, and biological activity of hybrid compounds between uramustine and DNA minor groove binder distamycin APier Giovanni Baraldi, Romeo Romagnoli, Antonio Entrena Guadix, et al.
Journal of Medicinal Chemistry|January 19, 2007
Synthesis and biological evaluation of novel 1-deoxy-1-[6-[((hetero)arylcarbonyl)hydrazino]- 9H-purin-9-yl]-N-ethyl-beta-D-ribofuranuronamide derivatives as useful templates for the development of A2B adenosine receptor agonistsPier Giovanni Baraldi, Delia Preti, Mojgan Aghazadeh Tabrizi, et al.
Mini Reviews in Medicinal Chemistry|June 23, 2007
Allosteric enhancers for A1 adenosine receptorPier Giovanni Baraldi, Maria Antonietta Iaconinoto, Allan R Moorman, et al.
Letters in Drug Design & Discovery|February 18, 2010
Discovery of 8-methoxypyrazino[1,2-a]indole as a New Potent Antiproliferative Agent Against Human Leukemia K562 Cells. A Structure-Activity Relationship StudyRomeo Romagnoli, Pier Giovanni Baraldi, Maria Dora Carrion, et al.
Journal of Medicinal Chemistry|March 1, 2013
Synthesis and biological evaluation of 2-(alkoxycarbonyl)-3-anilinobenzo[b]thiophenes and thieno[2,3-b]pyridines as new potent anticancer agentsRomeo Romagnoli, Pier Giovanni Baraldi, Maria Kimatrai Salvador, et al.
Journal of Medicinal Chemistry|October 16, 2004
Synthesis and biological evaluation of novel N6-[4-(substituted)sulfonamidophenylcarbamoyl]adenosine-5'-uronamides as A3 adenosine receptor agonistsPier Giovanni Baraldi, Francesca Fruttarolo, Mojgan Aghazadeh Tabrizi, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|November 30, 2007
Synthesis and biological evaluation of 2-amino-3-(3', 4', 5'-trimethoxy-phenylsulfonyl)-5-aryl thiophenes as a new class of antitubulin agentsRomeo Romagnoli, Pier Giovanni Baraldi, Vincent Remusat, et al.
Bioorganic & Medicinal Chemistry|June 29, 2010
Substituted 2-(3',4',5'-trimethoxybenzoyl)-benzo[b]thiophene derivatives as potent tubulin polymerization inhibitorsRomeo Romagnoli, Pier Giovanni Baraldi, Maria Dora Carrion, et al.
Pageof 16

Showing results (101-110 of 159) with videos related to

Sort By:
Pageof 16
Bioorganic & Medicinal Chemistry Letters|June 5, 2004
[3H]-MRE 2029-F20, a selective antagonist radioligand for the human A2B adenosine receptorsPier Giovanni Baraldi, Mojgan Aghazadeh Tabrizi, Delia Preti, et al.
Journal of Medicinal Chemistry|August 9, 2002
Synthesis, biological properties, and molecular modeling investigation of the first potent, selective, and water-soluble human A(3) adenosine receptor antagonistAnna Maconi, Giorgia Pastorin, Tatiana Da Ros, et al.
Journal of Medicinal Chemistry|August 9, 2002
Design, synthesis, and biological activity of hybrid compounds between uramustine and DNA minor groove binder distamycin APier Giovanni Baraldi, Romeo Romagnoli, Antonio Entrena Guadix, et al.
Journal of Medicinal Chemistry|January 19, 2007
Synthesis and biological evaluation of novel 1-deoxy-1-[6-[((hetero)arylcarbonyl)hydrazino]- 9H-purin-9-yl]-N-ethyl-beta-D-ribofuranuronamide derivatives as useful templates for the development of A2B adenosine receptor agonistsPier Giovanni Baraldi, Delia Preti, Mojgan Aghazadeh Tabrizi, et al.
Mini Reviews in Medicinal Chemistry|June 23, 2007
Allosteric enhancers for A1 adenosine receptorPier Giovanni Baraldi, Maria Antonietta Iaconinoto, Allan R Moorman, et al.
Letters in Drug Design & Discovery|February 18, 2010
Discovery of 8-methoxypyrazino[1,2-a]indole as a New Potent Antiproliferative Agent Against Human Leukemia K562 Cells. A Structure-Activity Relationship StudyRomeo Romagnoli, Pier Giovanni Baraldi, Maria Dora Carrion, et al.
Journal of Medicinal Chemistry|March 1, 2013
Synthesis and biological evaluation of 2-(alkoxycarbonyl)-3-anilinobenzo[b]thiophenes and thieno[2,3-b]pyridines as new potent anticancer agentsRomeo Romagnoli, Pier Giovanni Baraldi, Maria Kimatrai Salvador, et al.
Journal of Medicinal Chemistry|October 16, 2004
Synthesis and biological evaluation of novel N6-[4-(substituted)sulfonamidophenylcarbamoyl]adenosine-5'-uronamides as A3 adenosine receptor agonistsPier Giovanni Baraldi, Francesca Fruttarolo, Mojgan Aghazadeh Tabrizi, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|November 30, 2007
Synthesis and biological evaluation of 2-amino-3-(3', 4', 5'-trimethoxy-phenylsulfonyl)-5-aryl thiophenes as a new class of antitubulin agentsRomeo Romagnoli, Pier Giovanni Baraldi, Vincent Remusat, et al.
Bioorganic & Medicinal Chemistry|June 29, 2010
Substituted 2-(3',4',5'-trimethoxybenzoyl)-benzo[b]thiophene derivatives as potent tubulin polymerization inhibitorsRomeo Romagnoli, Pier Giovanni Baraldi, Maria Dora Carrion, et al.
Pageof 16